Cargando…
pncA Mutations in the Specimens from Extrapulmonary Tuberculosis
BACKGROUND: Pyrazinamide (PZA) is an effective antitubercular drug that becomes toxic to Mycobacterium tuberculosis when converted to pyrazinoic acid by pyrazinamidase (PZase), encoded by mycobacterial pncA. A strong association was noted between the loss of PZase activity and PZA resistance. The ca...
Autores principales: | Lee, Jaechun, Yun, Yeo-Jun, Kqueen, Cheah Yoke, Lee, Jong Hoo, Kim, Hee-Youn, Kim, Young Ree, Kook, Yoon-Hoh, Lee, Keun Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475457/ https://www.ncbi.nlm.nih.gov/pubmed/23101013 http://dx.doi.org/10.4046/trd.2012.72.6.475 |
Ejemplares similares
-
Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan
por: Chiu, Yu-Chi, et al.
Publicado: (2011) -
pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea
por: Park, Soon Kew, et al.
Publicado: (2001) -
Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
por: Lee, K. W., et al.
Publicado: (2001) -
Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis
por: Shi, Dawei, et al.
Publicado: (2022) -
Structure guided prediction of Pyrazinamide resistance mutations in pncA
por: Karmakar, Malancha, et al.
Publicado: (2020)